Oragenics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 23.95. In total, the insiders bought 2.7M and sold 4.47M OGEN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
23.95
Buy 2.7M shares
Sell 4.47M shares
64% Buy Activity
Moderate Negative Correlation
Buy Signal Medium Confidence
May 26, 2026

Analysis Breakdown:

  • Supported by a positive Insider Power Score of 23.95.
  • Confidence increased due to high data reliability score of 90.

Historical Insider Trades

Date Type Person Role Amount
Aug 08, 2023
Buy
Common Stock
A-Award
Murphy Kimberly M
CEO And President
CEO / President 25 000
Value: $0
Aug 08, 2023
Buy
Common Stock
A-Award
Pope Charles L
Director
Director 25 000
Value: $0
Aug 08, 2023
Buy
Common Stock
A-Award
Koski Robert C
Director
Director 25 000
Value: $0
Mar 07, 2023
Buy
Employee Option (Right to Buy)
A-Award
Huffman Janet
CFO, Secretary And Treasurer
C-Suite Officer 7 000
Value: $28.0K
Mar 07, 2023
Buy
Common Stock
J-Other
Huffman Janet
Officer
Officer 0
Value: $0
Mar 07, 2023
Buy
Common Stock
J-Other
Huffman Janet
Officer
Officer 0
Value: $0
Mar 07, 2023
Buy
Employee Option (Right to Buy)
A-Award
Huffman Janet
CFO, Secretary And Treasurer
C-Suite Officer 7 000
Value: $28.0K
Dec 30, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 42 357
Value: $4K
Dec 30, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 42 357
Value: $4K
Dec 29, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 36 648
Value: $4K
Dec 29, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 36 648
Value: $4K
Dec 15, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 140 497
Value: $24.7K
Dec 15, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 140 497
Value: $24.7K
Dec 14, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 25 000
Value: $4K
Dec 14, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 25 000
Value: $4K
Dec 14, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 4 503
Value: $788
Dec 14, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 4 503
Value: $788
Dec 09, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 48 795
Value: $10K
Dec 09, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 48 795
Value: $10K
Dec 08, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 13 036
Value: $3K
Dec 08, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 13 036
Value: $3K
Nov 30, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 200 000
Value: $38.2K
Nov 30, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 200 000
Value: $38.2K
Nov 29, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 200 000
Value: $38.5K
Nov 29, 2022
Sell
Common Stock
S-Sale
Koski Robert C
Director
Director 200 000
Value: $38.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ORAGENICS INC
Oragenics
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE